论文信息 - First-line ribociclib plus letrozole in postmenopausal women with HR+ , HER2− advanced breast cancer: Tumor response and pain reduction in the phase 3 MONALEESA-2 trial - 字舞流文

First-line ribociclib plus letrozole in postmenopausal women with HR+ , HER2− advanced breast cancer: Tumor response and pain reduction in the phase 3 MONALEESA-2 trial

P. Ward | F. Esteva | M. Campone | T. Pluard | W. Janni | E. Alba | T. Bachelot | R. López | P. Auñón | S. Sutradhar | M. Gil-Gil | Z. Král | S. Diab | Michelle Miller | L. Ryvo | P. Richards | T. Beck | M. Tsai